Singapore Retail Investors

UBS (Lux) Equity Fund - Asian Consumption (USD) (SGD) P-acc
Last update
22.01.2021
ISIN: LU0443062806
General information
Name of fund |
UBS (Lux) Equity Fund - Asian Consumption (USD) |
---|---|
Share class |
UBS (Lux) Equity Fund - Asian Consumption (USD) (SGD) P-acc |
ISIN |
LU0443062806 |
Fund domicile |
LU |
Fund type |
open-end |
Benchmark1) |
MSCI AC Asia ex Japan Consumer & Healthcare Sectors 10/40 Index |
Launch date |
01.09.2009 |
Currency of share class |
SGD |
Accounting year end |
30 November |
1) Reference index change on 30.04.2019 – old: MSCI AC Asia ex Japan Consumer & Healthcare Sectors index, new: customized MSCI AC Asia ex Japan Consumer & Healthcare Sectors 10/40 index.
Fund description
- Actively managed equity portfolio that invests throughout Asia in companies in the consumer staples, consumer discretionary and healthcare sectors.
- Efficient means of exploiting the potential of companies who offer goods and services to consumers in Asia. The focus lies on those companies who stand to benefit more from Asian consumer growth.
- Specialised sector analysts seek out the most attractive stocks mainly in the consumer goods and health care sector.
- The exchange rate risk between USD and SGD is not hedged.
Current fund data and tax figures
NAV Date |
22 Jan 2021 |
---|---|
Official NAV per share |
290.04 |
Total fund assets (USD m) |
208.73 |
Key benefits
- Easy access to the consumer sector in the Asian emerging markets.
- Offers investors broad diversification within the sector.
- The fund taps into the knowledge of proven sector specialists.
- UBS’s proprietary fundamental valuation approach enables the most attractive consumption companies to be consistently identified.
- The fund managers can also tap into the knowledge and experience of a network of equity analysts around the globe.
Performance chart (in fund currency)
Reference index change on 30.04.2019 – old: MSCI AC Asia ex Japan Consumer & Healthcare Sectors index, new: customized MSCI AC Asia ex Japan Consumer & Healthcare Sectors 10/40 index.
These figures refer to the past. Past performance is not a reliable indicator of future results. Fund performance is net of fees. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units.
Fees
Management fee p.a. |
1.63% |
---|---|
Total expense ratio (TER) p.a.1) |
2.10% |
Singapore Sales Charges (in %) |
3.00% |
1) as at 30.11.2019
Risks
UBS Sector Funds invest in equities and may therefore be subject to high fluctuations in value. For this reason, an investment horizon of at least five years and corresponding risk tolerance and capacity are required. Focusing intentionally on individual sectors may entail additional risks. All investments are subject to market fluctuations. Every fund has specific risks, which can significantly increase under unusual market conditions. The fund can use derivatives, which may result in additional risks (particularly counterparty risk).
The official NAV reflects the price in which investors can buy or sell units in the Fund. Please note that the adjusted NAV is not to be relied on for buying or selling of units in the Fund.